0001104659-24-058960.txt : 20240509 0001104659-24-058960.hdr.sgml : 20240509 20240508202914 ACCESSION NUMBER: 0001104659-24-058960 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240507 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240509 DATE AS OF CHANGE: 20240508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FENNEC PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001211583 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32295 FILM NUMBER: 24928130 BUSINESS ADDRESS: STREET 1: PO BOX 13628 STREET 2: 68 TW ALEXANDER DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: (919) 636-4530 MAIL ADDRESS: STREET 1: PO BOX 13628 STREET 2: 68 TW ALEXANDER DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: FENNEC PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20140903 FORMER COMPANY: FORMER CONFORMED NAME: ADHEREX TECHNOLOGIES INC DATE OF NAME CHANGE: 20021223 8-K 1 tm2413869d1_8k.htm FORM 8-K
false 0001211583 0001211583 2024-05-07 2024-05-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 7, 2024

 

FENNEC PHARMACEUTICALS INC.

(Exact name of registrant as specified in its charter)

 

001-32295

(Commission File Number)

 

British Columbia, Canada   20-0442384

(State or other jurisdiction of

incorporation)

   (I.R.S. Employer Identification No.)

 

PO Box 13628, 68 TW Alexander Drive,

Research Triangle Park, NC

  

 

27709

(Address of principal executive offices)   (Zip Code)

  

Registrant’s telephone number, including area code: (919) 636-4530

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12 of the Act:

 

Title of each class Trading symbol(s) Name of each exchange on which registered
Common shares, no par value FENC Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

Item 8.01. Other Events.

 

On May 7, 2024, Fennec Pharmaceuticals Inc. issued a news release announcing the Company will release its first quarter 2024 financial results before the opening of the U.S. financial markets on Tuesday, May 14, 2024. Management will host a conference call and webcast that day to discuss the Company’s financial and business results. A copy of the news release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information contained in this Current Report on Form 8-K, including the exhibit attached hereto, is being furnished and shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, unless such subsequent filing specifically references this Form 8-K.

  

 

 

 

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No. Description
   
Exhibit 99.1 Press Release dated May 7, 2024

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

    FENNEC PHARMACEUTICALS INC.
     
Date May 8, 2024 By: /s/ Robert Andrade
    Robert Andrade
    Chief Financial Officer

 

 

 

 EX-99.1 2 tm2413869d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1 

 

 

Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024

 

RESEARCH TRIANGLE PARK, N.C., May 7, 2024 – Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2024 financial results before the opening of the U.S. financial markets on Tuesday, May 14, 2024. Management will host a conference call and webcast that day to discuss the Company’s financial and business results.

 

Conference Call & Webcast Detail:

 

Date: Tuesday, May 14, 2024
Time: 8:30 a.m. Eastern Time
Link: https://register.vevent.com/register/BI137d97d6710341398d6f17d0433dc5b8

 

To access the conference call, please register using https://register.vevent.com/register/BI137d97d6710341398d6f17d0433dc5b8. Upon registration, a dial-in number and unique PIN will be provided to join the call. To access the live webcast link, log onto www.fennepharma.com and proceed to the News & Events / Event Calendar page under the Investors & Media heading. Please connect to the company’s website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to listen to the webcast. A webcast replay of the conference call will also be archived on www.fennecpharma.com for thirty days.

 

About Fennec Pharmaceuticals

 

Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of PEDMARK® and PEDMARQSI® to reduce the risk of platinum-induced ototoxicity in pediatric patients. PEDMARK received FDA approval in September 2022 and European Commission Marketing Authorization in June 2023 for PEDMARQSI. Further, PEDMARQSI received U.K. approval in October 2023. PEDMARK has received Orphan Drug Exclusivity in the U.S. for seven years of market protection and PEDMARQSI has received Pediatric Use Marketing Authorization in Europe, which includes eight years plus two years of data and market protection. For more information, please visit www.fennecpharma.com.

 

For further information, please contact:

 

Investors:
Robert Andrade
Chief Financial Officer
Fennec Pharmaceuticals Inc.
+1 919-246-5299

 

Corporate & Media:
Lindsay Rocco

Elixir Health Public Relations
+1 862-596-1304
lrocco@elixirhealthpr.com

 

 

 EX-101.SCH 3 fencf-20240507.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 fencf-20240507_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 fencf-20240507_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 tm2413869d1_ex99-1img001.jpg GRAPHIC begin 644 tm2413869d1_ex99-1img001.jpg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end XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover
May 07, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 07, 2024
Entity File Number 001-32295
Entity Registrant Name FENNEC PHARMACEUTICALS INC.
Entity Central Index Key 0001211583
Entity Tax Identification Number 20-0442384
Entity Incorporation, State or Country Code A1
Entity Address, Address Line One PO Box 13628
Entity Address, Address Line Two 68 TW Alexander Drive
Entity Address, City or Town Research Triangle Park
Entity Address, State or Province NC
Entity Address, Postal Zip Code 27709
City Area Code 919
Local Phone Number 636-4530
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common shares, no par value
Trading Symbol FENC
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://adherex.com/role/Cover Cover Cover 1 false false All Reports Book All Reports fencf-20240507.xsd fencf-20240507_lab.xml fencf-20240507_pre.xml tm2413869d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm2413869d1_8k.htm": { "nsprefix": "fencf", "nsuri": "http://adherex.com/20240507", "dts": { "schema": { "local": [ "fencf-20240507.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "fencf-20240507_lab.xml" ] }, "presentationLink": { "local": [ "fencf-20240507_pre.xml" ] }, "inline": { "local": [ "tm2413869d1_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://adherex.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-05-07", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2413869d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-05-07", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2413869d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://adherex.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001104659-24-058960-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-058960-xbrl.zip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end XML 18 tm2413869d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001211583 2024-05-07 2024-05-07 iso4217:USD shares iso4217:USD shares false 0001211583 8-K 2024-05-07 FENNEC PHARMACEUTICALS INC. 001-32295 A1 20-0442384 PO Box 13628 68 TW Alexander Drive Research Triangle Park NC 27709 919 636-4530 false false false false Common shares, no par value FENC NASDAQ false